Gilead's ARTISTRY-2 trial shows BIC/LEN is non-inferior to Biktarvy in virologically suppressed adults with HIV, with no new safety signals. ARTISTRY-2's design involved a randomized, double-blind ...

Data from FDA-advised study demonstrates Lumee™ Oxygen tissue monitoring is a safe and effective long-term method in PAD ...

At CDMI Europe 2025, experts agreed that AI is the key technology to improve efficiencies in clinical trial data management.

P72, a HER2 × CD3 T cell engager, with preclinical studies demonstrating enhanced HER2-high tumor selectivity and a favorable ...

Kyverna Therapeutics, Inc. shares surged on strong Phase 2 KYSA-8 data for Miv-cel in stiff person syndrome. Read why KYTX ...

Miroma Project Factory (MPF) has delivered a bespoke mobile solution for Screen2Quit, part of the International Lung Study trial and one of Australia's most ambitious research studies targeting ...

Mass General Brigham is announcing the spinout of AIwithCare, a company founded by researchers who created a Retrieval-Augmented Generation (RAG)–based AI tool that greatly outperforms manual review ...

Technology maturity: Technology has reached a level of maturity that allows integration of various systems and devices to be seamless. Connected health devices and cloud platforms have evolved from ...

Discover why IQVIA Holdings leads in life sciences data & tech with AI-driven services, strong growth, and up to 30% stock ...

Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...